लोड हो रहा है...
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
Src homology containing protein tyrosine phosphatase 2 (SHP2) represents a noteworthy target for various diseases, serving as a well-known oncogenic phosphatase in cancers. As a result of the low cell permeability and poor bioavailability, the traditional inhibitors targeting the protein tyrosine ph...
में बचाया:
| में प्रकाशित: | Acta Pharm Sin B |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Elsevier
2021
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7838030/ https://ncbi.nlm.nih.gov/pubmed/33532178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.07.010 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|